SMED Key Statistics, Chart & Performance
The current stock price of SMED is 8.75 USD. In the past month the price increased by 1.39%. In the past year, price decreased by -7.99%.
SMED Latest News, Press Relases and Analysis
SMED Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.39 | 98.97B | ||
| CI | THE CIGNA GROUP | 9.79 | 74.23B | ||
| LH | LABCORP HOLDINGS INC | 16.79 | 22.07B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.6 | 21.39B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 108.86 | 19.67B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.15B | ||
| DVA | DAVITA INC | 13.03 | 8.60B | ||
| HIMS | HIMS & HERS HEALTH INC | 64.28 | 7.85B | ||
| CHE | CHEMED CORP | 20.08 | 6.44B | ||
| RDNT | RADNET INC | 218.42 | 6.38B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 33.91 | 6.13B | ||
| OPCH | OPTION CARE HEALTH INC | 19.85 | 4.80B |
Related stock screener links
About SMED
Company Profile
Sharps Compliance Corp. engages in the provision of healthcare waste management services including medical, pharmaceutical, and hazardous. The company is headquartered in Houston, Texas and currently employs 190 full-time employees. The firm's services includes medical, pharmaceutical and hazardous for small and medium quantity generators. The firm's lead products are the Sharps Recovery System and MedSafe Medication Disposal System. The Sharps Recovery System is a comprehensive medical waste management mailback solution used in all markets due to its availability. The MedSafe solution meets the immediate needs of an increasing community risk associated with unused, ultimate-user, medications. The firm also offers its route-based pick-up services in approximately 37 state regions of the South, Southeast, Southwest, Midwest and Northeast portions of the United States.
Company Info
SHARPS COMPLIANCE CORP
Ste 500, 9220 Kirby Drive
Houston TEXAS 77054 US
CEO: David P. Tusa
Employees: 190
Phone: 17134320300.0
SHARPS COMPLIANCE CORP / SMED FAQ
What does SHARPS COMPLIANCE CORP do?
Sharps Compliance Corp. engages in the provision of healthcare waste management services including medical, pharmaceutical, and hazardous. The company is headquartered in Houston, Texas and currently employs 190 full-time employees. The firm's services includes medical, pharmaceutical and hazardous for small and medium quantity generators. The firm's lead products are the Sharps Recovery System and MedSafe Medication Disposal System. The Sharps Recovery System is a comprehensive medical waste management mailback solution used in all markets due to its availability. The MedSafe solution meets the immediate needs of an increasing community risk associated with unused, ultimate-user, medications. The firm also offers its route-based pick-up services in approximately 37 state regions of the South, Southeast, Southwest, Midwest and Northeast portions of the United States.
Can you provide the latest stock price for SHARPS COMPLIANCE CORP?
The current stock price of SMED is 8.75 USD. The price increased by 0.11% in the last trading session.
What is the dividend status of SHARPS COMPLIANCE CORP?
SMED does not pay a dividend.
How is the ChartMill rating for SHARPS COMPLIANCE CORP?
SMED has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the Price/Earnings (PE) ratio of SHARPS COMPLIANCE CORP (SMED)?
The PE ratio for SHARPS COMPLIANCE CORP (SMED) is 46.05. This is based on the reported non-GAAP earnings per share of 0.19 and the current share price of 8.75 USD.
What is SHARPS COMPLIANCE CORP worth?
SHARPS COMPLIANCE CORP (SMED) has a market capitalization of 170.01M USD. This makes SMED a Micro Cap stock.
SMED Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to SMED. When comparing the yearly performance of all stocks, SMED is one of the better performing stocks in the market, outperforming 98.19% of all stocks.
SMED Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to SMED. While SMED has a great health rating, its profitability is only average at the moment.
SMED Financial Highlights
Over the last trailing twelve months SMED reported a non-GAAP Earnings per Share(EPS) of 0.19. The EPS decreased by -67.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.25% | ||
| ROA | 2.89% | ||
| ROE | 4.19% | ||
| Debt/Equity | 0.06 |
SMED Forecast & Estimates
9 analysts have analysed SMED and the average price target is 7.52 USD. This implies a price decrease of -14.03% is expected in the next year compared to the current price of 8.75.
For the next year, analysts expect an EPS growth of -96.71% and a revenue growth -19.46% for SMED